We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDL
12826
CALL
Cardiol Therapeutics
CRDL
$164M
$39K ﹤0.01%
25,300
-51,500
-67% -$84.9K
EVAX
12827
Evaxion A/S
EVAX
$25.9M
$39K ﹤0.01%
+255
New +$42K
GSAT icon
12828
Globalstar
GSAT
$10.8B
$39K ﹤0.01%
1,787
-34,769
-95% -$591K
SEGG
12829
Sports Entertainment Gaming Global Corp
SEGG
$8.25M
$39K ﹤0.01%
9
-3
-25% -$17.2K
LVO icon
12830
PUT
LiveOne
LVO
$58.2M
$39K ﹤0.01%
4,760
-3,010
-39% -$26.2K
MBIO icon
12831
Mustang Bio
MBIO
$4.55M
$39K ﹤0.01%
51
-138
-73% -$113K
NGNE icon
12832
Neurogene
NGNE
$712M
$39K ﹤0.01%
1,017
+153
+18% +$8.93K
SIFY
12833
Sify Technologies
SIFY
$1.14B
$39K ﹤0.01%
2,199
-1,038
-32% -$19K
TALK icon
12834
Talkspace
TALK
$874M
$39K ﹤0.01%
22,552
-2,534
-10% -$3.96K
CNTN
12835
Canton Strategic Holdings
CNTN
$144M
$39K ﹤0.01%
+65
New +$61.2K
TRVG
12836
CALL
trivago
TRVG
$397M
$39K ﹤0.01%
3,280
-19,620
-86% -$221K
WKEY
12837
WISeKey
WKEY
$74M
$39K ﹤0.01%
+3,020
New +$49.3K
SPECW
12838
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$39K ﹤0.01%
157,718
+21,542
+16% +$6.68K
APTX
12839
CALL
DELISTED
Aptinyx Inc. Common Stock
APTX
$39K ﹤0.01%
17,300
-1,700
-9% -$5.09K
FHS
12840
DELISTED
First High-School Education Group Co., Ltd. American Depositary Shares (each representing three (3) Class A Ordinary Shares)
FHS
$39K ﹤0.01%
26,216
-58,133
-69% -$98.5K
BLCT
12841
DELISTED
BlueCity Holdings Limited American Depositary Shares
BLCT
$39K ﹤0.01%
29,431
+7,089
+32% +$10.1K
CIK
12842
Credit Suisse Asset Management Income Fund
CIK
$134M
$38K ﹤0.01%
12,497
-20,122
-62% -$64.3K
CRBP icon
12843
Corbus Pharmaceuticals
CRBP
$190M
$38K ﹤0.01%
2,379
-32,498
-93% -$431K
CTMX icon
12844
CytomX Therapeutics
CTMX
$754M
$38K ﹤0.01%
14,382
-23,688
-62% -$91K
EVAX
12845
PUT
Evaxion A/S
EVAX
$25.9M
$38K ﹤0.01%
250
-28
-10% -$4.61K
NERV icon
12846
CALL
Minerva Neurosciences
NERV
$199M
$38K ﹤0.01%
5,663
-3,212
-36% -$19.7K
PLX icon
12847
CALL
Protalix BioTherapeutics
PLX
$198M
$38K ﹤0.01%
35,700
+2,600
+8% +$2.38K
HIND
12848
Vyome Holdings
HIND
$15.2M
0
VTGN icon
12849
PUT
VistaGen Therapeutics
VTGN
$12.8M
$38K ﹤0.01%
1,013
-1,317
-57% -$57.4K
BLNE
12850
PUT
Beeline Holdings
BLNE
$33.2M
$38K ﹤0.01%
197
-169
-46% -$38.5K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.